Moderator(s): Jefferson Wilson, MD, PhD, FRSC
1. Use of ALIF at the lumbosacral junction results in less lumbopelvic fixation failure than TLIF or no interbody fusion following correction of adult spinal deformity
Robert K. Eastlack, MD1; Alexandra Soroceanu, MD, MPH2; Gregory M. Mundis Jr., MD3; Justin S. Smith, MD, PhD4; Breton Line, BS5; Peter G. Passias, MD6; Pierce D. Nunley, MD7; David O. Okonkwo, MD8; Khoi D. Than, MD9; Juan S. Uribe, MD10; Dean Chou, MD11; Khaled M. Kebaish, MD12; Christopher I. Shaffrey, MD9; Shay Bess, MD13; International Spine Study Group14
1Scripps Clinic, San Diego, CA, US; 2University of Calgary, Calgary, Canada; 3Scripps Clinic Medical Group, Department of Orthopedics, La Jolla, CA, US; 4UVA Health System, Charlottesville, VA, US; 5Denver International Spine Center, Denver, CO, US; 6NY Spine Institute, NYU Langone Health, New York, NY, US; 7Spine Institute of Louisiana, Shreveport, LA, US; 8Pittsburgh, PA, US; 9Duke University, Durham, NC, US; 10Barrow Neurological Institute, Phoenix, AZ, US; 11University of California San Francisco, San Francisco, CA, US; 12Johns Hopkins University, Baltimore, MD, US;13Denver, CO, US; 14Brighton, CO, US;
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
2. The re-herniation after decompression (RAD) score identifies patients at low-risk for re-herniation after lumbar decompression surgery
Garrett Harada, MD1;Bryce Basques, MD, MHS2; Alexander Hornung, BS3; Dino Samartzis, ScD, PhD, MSc4; Howard S. An, MD5
1Los Angeles, CA, US; 2Thomas Jefferson University, Philadelphia, PA, US; 3Midwest Orthopedics at Rush, Chicago, IL, US; 4Queen Mary Hospital, Hong Kong, Hong Kong; 5Rush University Medical Center, Department of Orthopedic Surgery, Chicago, IL, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
3. Global Spine Outreach (GSO): how to safely establish a sustainable short-term spine deformity outreach program
Gregory M. Mundis Jr., MD1;Fernando Rios, MD2; Lesley Mundis, PA-C2; Melissa Hicks3
1Scripps Clinic Medical Group, Department of Orthopedics, La Jolla, CA, US; 2San Diego, CA, US; 3Global Spine Outreach, Nashville, TN, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
4. At what point should the thoracolumbar region be addressed in patients undergoing corrective cervical deformity surgery?
Peter G. Passias, MD1; Katherine E. Pierce, BS2; Virginie Lafage, PhD3; Renaud Lafage, MSc3; Eric O. Klineberg, MD4; Bassel G. Diebo, MD5; Themistocles S. Protopsaltis, MD6; D. Kojo Hamilton, MD7; Shaleen N. Vira, MD8; Breton Line, BS9; Robert A. Hart, MD10; Douglas C. Burton, MD11; Shay Bess, MD12; Frank J. Schwab, MD3; Christopher I. Shaffrey, MD13; Justin S. Smith, MD, PhD14; Christopher P. Ames, MD15; International Spine Study Group16
1NY Spine Institute, NYU Langone Health, New York, NY, US; 2NYU Spine Research Lab, New York, NY, US; 3Hospital for Special Surgery, New York, NY, US; 4UC, Davis School of Medicine, Sacramento, CA, US; 5Department of Orthopaedic Surgery, SUNY Downstate Medical Center, Brooklyn, NY, US; 6Department of Orthopaedic Surgery, NYU Langone Orthopaedic Hospital, NYU Langone Health, New York, NY, US; 7University of Pittsburgh School of Medicine, Pittsburgh, PA, US; 8Department of Orthopaedic Surgery, UT Southwestern Medical Center, Dallas, TX, US; 9Denver International Spine Center, Denver, CO, US; 10Swedish Neuroscience Institute, Seattle, WA, US; 11University of Kansas Medical Center, Kansas City, KS, US; 12Denver, CO, US; 13Duke University, Durham, NC, US; 14UVA Health System, Charlottesville, VA, US; 15University of California, San Francisco, San Francisco, CA, US; 16Brighton, CO, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
5. Are octogenarians at higher risk for complications after elective lumbar spinal fusion surgery compared with younger patients? A study from the Kaiser Permanente National Spine Registry
T. Kent Ganocy II, MD1; Kathryn Royse, PhD, MPH2; Heather Prentice, PhD, MPH3; Jessica E. Harris, MS3; Calvin C. Kuo, MD4
1Southern California Permanente Medical Group, Los Angeles, CA, US; 2San Diego, CA, US; 3Kaiser Permanente, San Diego, CA, US; 4Kaiser Permanente, Oakland, CA, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
6. PLF or ALIF+PS: which has a lower operative nonunion rate? Analysis of a cohort of 2,061 patients from a national spine registry
Elizabeth P. Norheim, MD1; Kathryn Royse, PhD, MPH2; Harsimran Brara, MD3; David J. Moller, MD4; Patrick W. Suen, MD5; Shayan Rahman, MD6; Jessica E. Harris, MS7; Kern H. Guppy, MD, PhD8
1Kaiser Permanente, Los Angeles, CA, US; 2San Diego, CA, US; 3Southern California Permanente Medical Group, Los Angeles, CA, US; 4University of California, Davis, Sacramento, CA, US; 5Kaiser Permanente, San Jose, CA, US; 6Ann Arbor, MI, US; 7Kaiser Permanente, San Diego, CA, US; 8Kaiser Permanente Medical Group, Sacramento, CA, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
7.Mild and severe obesity reduce effectiveness of lumbar fusions: one-year patient-reported outcomes in 8,171 patients
Olivia Rice, MD1; Joshua C. Patt, MD, MPH2; Anthony L. Asher, MD3; Matthew J. McGirt, MD3
1Charlotte, NC, US; 2Carolinas Medical Center, Charlotte, NC, US; 3Carolina Neurosurgery & Spine Associates, Charlotte, NC, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
Discussion